Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Jun 30, 2025 | (FY)Mar 31, 2025 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 23.54%31.79B | 27.98%107.41B | 21.94%25.73B | -11.62%83.93B | -6.42%21.09B | -7.84%22.55B | -14.42%19.19B | -17.37%21.1B | 1.92%94.96B | 7.81%22.54B |
| Cost of revenue | 19.20%20.05B | 17.92%71.06B | 12.05%16.82B | -11.65%60.26B | -8.24%15B | -7.98%15.99B | -13.60%14.26B | -16.52%15.01B | 4.94%68.2B | 6.11%16.35B |
| Gross profit | 31.71%11.74B | 53.60%36.36B | 46.32%8.91B | -11.54%23.67B | -1.62%6.09B | -7.49%6.56B | -16.74%4.93B | -19.41%6.09B | -5.04%26.76B | 12.57%6.19B |
| Operating expense | -2.02%3.06B | 23.37%13.05B | 23.08%3.13B | 5.73%10.57B | 13.58%2.74B | 1.52%2.75B | -2.34%2.55B | 11.70%2.54B | 7.33%10B | 24.68%2.42B |
| Selling and administrative expenses | -2.16%3.44B | 21.46%14.3B | 23.18%3.52B | 6.62%11.78B | 14.32%2.99B | 5.93%2.98B | 3.87%2.95B | 2.99%2.86B | 8.03%11.04B | 4.73%2.61B |
| -General and administrative expense | -2.16%3.44B | 21.46%14.3B | 23.18%3.52B | 6.62%11.78B | 14.32%2.99B | 5.93%2.98B | 3.87%2.95B | 2.99%2.86B | 8.03%11.04B | 4.73%2.61B |
| Other operating expenses | 150.00%30M | -66.90%48M | -36.84%12M | -46.49%145M | -35.82%43M | -79.22%32M | 42.86%50M | 35.71%19M | -87.18%271M | 770.00%67M |
| Total other operating income | 1.23%410M | -3.05%1.31B | 20.54%405M | 2.44%1.35B | 8.33%286M | 1.50%270M | 69.14%455M | -34.63%336M | -56.48%1.31B | -51.74%264M |
| Operating profit | 49.92%8.68B | 78.01%23.31B | 62.93%5.79B | -21.85%13.1B | -11.35%3.34B | -13.06%3.81B | -28.05%2.39B | -32.78%3.55B | -11.16%16.76B | 5.98%3.77B |
| Net non-operating interest income (expenses) | -147.45%-130M | -42.94%400M | -38.98%274M | 342.56%701M | 361.94%351M | 50.45%-167M | 130.00%69M | 199.33%449M | -244.05%-289M | 0.00%-134M |
| Non-operating interest income | -53.49%173M | -30.81%741M | -29.94%372M | 171.83%1.07B | 1,229.41%452M | 281.03%221M | 187.36%250M | 146.98%531M | 20.12%394M | 78.95%34M |
| Non-operating interest expense | 209.18%303M | -7.84%341M | 19.51%98M | -45.83%370M | -39.88%101M | -1.77%388M | 217.54%181M | 26.15%82M | 65.78%683M | 9.80%168M |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | 0 | -1M | 0 | |||||||
| Special income (charges) | ||||||||||
| Other non-operating income (expenses) | ||||||||||
| Income before tax | 40.97%8.55B | 71.87%23.71B | 51.58%6.06B | -16.23%13.8B | 1.57%3.7B | -9.92%3.64B | -26.63%2.46B | -26.42%4B | -12.30%16.47B | 6.22%3.64B |
| Income tax | -2.27%2.28B | 34.02%7.53B | 19.26%2.33B | -0.12%5.62B | -4.26%1.24B | 0.07%1.4B | -8.73%1.03B | 7.94%1.96B | -8.66%5.62B | 19.08%1.29B |
| Net income | 68.05%6.27B | 97.85%16.18B | 82.48%3.73B | -24.57%8.18B | 4.77%2.46B | -15.14%2.25B | -35.71%1.43B | -43.61%2.04B | -14.06%10.85B | 0.34%2.35B |
| Net income continuous operations | 68.05%6.27B | 97.85%16.18B | 82.48%3.73B | -24.57%8.18B | 4.77%2.46B | -15.14%2.25B | -35.71%1.43B | -43.61%2.04B | -14.06%10.85B | 0.34%2.35B |
| Noncontrolling interests | 100.88%2.05B | 88.44%5.28B | 38.48%1.02B | -10.99%2.8B | -2.05%715M | -4.17%804M | -17.95%544M | -19.34%738M | 0.48%3.15B | 21.46%730M |
| Net income attributable to the company | 55.71%4.21B | 102.77%10.9B | 107.44%2.71B | -30.14%5.38B | 7.86%1.74B | -20.24%1.44B | -43.28%886M | -51.83%1.3B | -18.88%7.7B | -7.07%1.62B |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 55.71%4.21B | 102.77%10.9B | 107.44%2.71B | -30.14%5.38B | 7.86%1.74B | -20.24%1.44B | -43.28%886M | -51.83%1.3B | -18.88%7.7B | -7.07%1.62B |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 57.50%90.12 | 105.69%231.55 | 110.37%57.22 | -29.37%112.57 | 9.24%36.65 | -19.42%30.2 | -42.58%18.53 | -51.49%27.2 | -16.98%159.39 | -6.86%33.55 |
| Diluted earnings per share | 57.65%88.98 | 105.83%228.55 | 110.36%56.44 | -29.42%111.04 | 8.73%36.13 | -19.63%29.8 | -42.72%18.29 | -51.16%26.83 | -16.34%157.33 | -5.92%33.23 |
| Dividend per share | 0 | 22.92%59 | 0 | 4.35%48 | 0.00%24 | 0 | 9.09%24 | 0 | 15.00%46 | 9.09%24 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |